Grant of Series 7 Stock Acquisition Rights to 56 Employees
First written in FY2025-H1. . Latest entry: FY2026.
18 other companies' latest entry also says "Other".
- FY2026Reduction in Series 7 stock acquisition rightsAnnual report
「Series 7 stock acquisition rights Number of stock acquisition rights: 217 [211] (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 21,700 [21,100] (Notes 1 and 3)」
Series 7 rights declined from 219 to 217 at fiscal year-end and 211 at the end of the month preceding the filing date, with the underlying shares declining to 21,700 and 21,100, respectively. - FY2026-H1Further reduction in Series 7 stock acquisition rightsAnnual report
「Series 7 stock acquisition rights approved by the Board of Directors on 17 October 2024 Number of stock acquisition rights: 219 (Common shares: 21,900)」
Series 7 rights declined from the previously reported 224 to 219, representing 21,900 shares. - FY2025Fewer rights and grantees after the grantAnnual report
「Due to the loss of rights caused by grantees leaving the company, as of the end of the month preceding the month-end immediately preceding the date of filing this document, the grantees comprised 1 company director and 49 company employees.」
At fiscal year-end, the Series 7 rights were held by 1 director and 51 employees and comprised 224 rights representing 22,400 common shares. By the end of the month preceding the filing date, the number of grantees had declined to 1 director and 49 employees after rights were lost due to departures. - FY2025-H1First statedAnnual report
「Category and number of grantees (people)* Company employees: 56 Number of stock acquisition rights (units)* 290 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 29,000 (Note 1) Exercise period for stock acquisition rights* From 1 November 2026 to 16 October 2034」
For the Series 7 stock acquisition rights approved on 17 October 2024, 290 rights representing 29,000 common shares were granted to 56 employees, with an exercise period from November 2026 through October 2034.